Global leader in developing vaccines and therapeutics against HIV, COVID-19, and influenza, ready to respond to any new emerging infectious disease threats.
Durham, NC
Joined February 2018
- Tweets1.4K
- Following190
- Followers1.2K
- Likes1.1K
Pinned Tweet
The Duke Human Vaccine Institute is sharing news, research, and departmental highlights on LinkedIn.
Follow us to stay informed and connected: linkedin.com/company/thedhvi
Congratulations to Georgia Tomaras, PhD, recipient of Duke School of Medicine's 2025 Faculty Award for Research Mentoring, recognizing excellence in mentoring across clinical, translational, population health, and basic sciences. Read about the recipients medschool.duke.edu/news/duke…
Experts from DHVI, @PennMedicine & @harvardmed share the successes and challenges in the quest to develop an HIV vaccine in, “Status of HIV Vaccine Development: Progress and Promise”, published in @jiasociety for #HIVVaccineAwarenessDay. Read the article 🔗bit.ly/3FhjTQI
Duke Human Vaccine Institute retweeted
.@Duke_Neurology's Laurie Sanders, PhD, whose lab is pioneering early detection of Parkinson’s, cautions that losing NIH funding could hinder future scientific breakthroughs.
🔗 Read more: medschool.duke.edu/stories/f…
@DukeU
ALT Two researchers, one using a microscope, in a laboratory setting, engaging in scientific work.
Duke Human Vaccine Institute retweeted
DCI's Jenny Freedman, PhD, explains how a natural gene-splicing process can run amuck, producing prostate cancer cells. Her team's discovery provides a promising new target for cancer treatment.
duke.is/r/4n3u
@DukeHealth | @dukemedicine
ALT Steve Patierno, PhD, Jennifer Freedman, PhD, and Dan George, MD, review data in the Patierno, Freedman George lab at Duke Cancer Institute.
A group of scientists at Duke and Harvard Universities have conducted a study that may show new promise for a potential HIV vaccine. Their vaccine produces antibodies that are broadly neutralizing against more than a third of the HIV strains in the U.S.
anl.gov/article/new-hiv-vacc…
Duke Human Vaccine Institute retweeted
Uniting 24 labs across 11 institutions to tackle HIV-1 challenges, discover the groundbreaking work of @DukeHIVStrucBio! See how their work on HIV-1 entry, B-cell receptors & more is paving the way for potential cures. @TheDHVI @BiophysicalSoc #bps2025 youtu.be/jLk77Uy-euE
Duke Human Vaccine Institute retweeted
Duke University School of Medicine has been named a Global Virus Network (GVN) Center of Excellence. This recognition highlights Duke's significant contributions to virus research and global health. @TheDHVI @DukeGHI
medschool.duke.edu/news/duke…
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.
corporate.dukehealth.org/new…
Duke Human Vaccine Institute retweeted
New research by #DukeCTSI and Duke SSRI examines the trust and perspective of providers, patients and caregivers when they considered using machine learning-based prediction models for patients with kidney failure on dialysis.
Details in @JAMIA_Journal: duke.is/p/tjkc
ALT Stock image of a healthcare provider with a patient who is undergoing kidney dialysis.
Duke Human Vaccine Institute retweeted
Sore throat, cough, fever, and ear pain? Is it better to head to an urgent care or the emergency department if you’re having cold and flu-like symptoms? Follow along with the video below to test your knowledge and learn more.
@DukeHospital | @DukeRegional | @DukeRaleigh
Duke Human Vaccine Institute retweeted
🎉Congratulations to affiliate #DukeCTSI faculty @Keisha_Bentley and @senthil_selv, named to the 2025 Office for Faculty leadership programs at @DukeMedSchool!
Dr. Bentley-Edwards joins ALICE: duke.is/y/ax5n
Dr. Selvaraj joins LEADER: duke.is/v/4mq3
ALT Keisha Bentley-Edwards, PhD, and Senthil Selvaraj, MD
Duke Human Vaccine Institute retweeted
Meet Associate Scientist and Process Engineer with @TheDHVI, David Clarke! He has been working with the DHVI Good Manufacturing Program for seven years. He encourages junior scientists to use any opportunity for hands-on, experiential learning. #meetCIVICs
ALT David Clarke , Duke VMTC, Associate scientist II GMP/ Process Engineer II, Duke Human Vaccine Institute , What's your research focus?, For 7 years, I’ve worked with the DHVI Good Manufacturing Program (DGP) to manufacture bulk drug substance & bulk drug product for phase 1 clinical trials. I've had the opportunity to work on novel HIV, flu, & COVID-19 vaccine platforms spanning from monoclonal antibodies to mRNAs., Do you have any advice for junior scientists?, Experiential learning is the best type of learning!, What was the last technique you used in lab?, Ultrafiltration and diafiltration
Duke Human Vaccine Institute retweeted
Graduate student Ellie Zhang's cryo-EM structure, beautifully rendered by @swansolive made the cover of Science Translational Medicine. @dukebiochem @TheDHVI @DukeMedSchool @DukeU @AzoiteiLab
This week's issue of #ScienceTranslationalMedicine has arrived!
Personalized electric stimulation shows promise in two patients with spinal cord injuries, a study shows that Staph bacteria rapidly evolve resistance to new antibiotic candidates, and more. scim.ag/4j0qH4i
Duke Human Vaccine Institute retweeted
@DukeCancer formed a working group to tackle an alarming trend: the rising rates of young-onset gastrointestinal cancers. The group of experts representing diverse disciplines aims to identify significant risk factors in patients under 50.
Read more ➡️ duke.is/YOGI
Highly specific HIV antibodies could be induced by vaccination using a new strategy developed by DHVI researchers. Vaccination using this strategy may be able to counter the virus’s ability to outpace the immune system.
corporate.dukehealth.org/new…
Go to work with a view! You could make a difference in global health while providing essential support to researchers at the Duke Regional Biocontainment Laboratory as Program Assistant. If you have experience in office management & budgeting, apply at duke.is/5/rzfj.
Take your research career to the next level in the @lab_haynes as a Research Technician III. You'll play a critical role in characterizing immune responses using new & advanced techniques & work w/various specimens in a highly collaborative environment - duke.is/r/2qku.
We're #hiring a Program Assistant. Make a difference in global health while providing essential support to researchers & staff at the Duke Regional Biocontainment Laboratory (RBL). You'll play a vital role in supporting investigators and staff. Apply now- duke.is/5/rzfj.